ALEXANDRIA, Va., Feb. 11 -- United States Patent no. 12,544,420, issued on Feb. 10, was assigned to OLD DOMINION UNIVERSITY RESEARCH FOUNDATION (Norfolk, Va.).
"Electroporation-targeted delivery of ribosome inactivating protein gelonin into mammalian cells" was invented by Andrei Pakhomov (Norfolk, Va.) and Olga Pakhomova (Norfolk, Va.).
According to the abstract* released by the U.S. Patent & Trademark Office: "A method of treating a target tissue area with a ribosome-inactivating protein. The method comprises injecting the target tissue area with an effective dose of a ribosome-inactivating protein and administering electroporation therapy to the target tissue area."
The patent was filed on March 25, 2025, under Application No. 19/089,...